|
⚲
|
| Keyboard |
| Platform Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002152141 |
| Sale | 2026-08-12 (4.0 M Offered, 1.8 M Sold) |
| Fund | |
| Phone | 3392240265 |
| Address | 300 Brickstone Square, Ste 201 Andover, MA 01810 |
| Source | [EDGAR] |
| Amount Raised ($k) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-08-27 (D) |
| Exemption | 506(b) |
| Remaining | $2,250,000 |
| Duration | One year or less |
| Revenue | Not Applicable |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Lakhmir Chawla | Director | |
| James Wilkie | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Bain Capital Everest Manager Holding SCA
✚
|
MA | |
|
Glasswing Ventures LLC
✚
|
MA | |
|
Delta Partners LP
✚
|
MA | |
|
Longwood Management LLC
✚
|
MA | |
|
Highland Capital Partners LLC
✚
|
MA | |
|
TA Associates LP
✚
|
MA | |
|
Greenwood Investments Inc
✚
|
MA | |
|
Windham Capital Management LLC
✚
|
MA | |
|
Bain Capital Fund X LP
✚
|
MA | |
|
Castine Capital Management LLC
✚
|
MA |